Phase 4 Multiple sclerosis trials recruiting now

All Multiple sclerosis trials, every phase

Other phases for Multiple sclerosis

Phase 4 Multiple sclerosis trials

• A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
  NCT07609719 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
  NCT06733922 · Phase: Phase 4 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 14 locations
• Glucose Consumption in MS Using [F-18]FDG-PET
  NCT07087106 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Home Based Infusions for Ocrelizumab
  NCT04650321 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities
  NCT07303582 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
  NCT05285891 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 13 locations
• Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
  NCT06529406 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
  NCT04480853 · Phase: Phase 4 · Ages: 20 Years to 100 Years · Sex: All (male and female) · 6 locations
• Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
  NCT07614321 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 1 location
• Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
  NCT07389590 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
  NCT07225361 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.